Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine
Clinical trial NCT02745392 · COMPLETED
Trial details
- NCT number
- NCT02745392
- Sponsor
- Zosano Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-01-01
- Enrollment
- 365
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.